Physician profile
Scott E Smith
NPI 1275586695
$1,272.92
in general payments reported to CMS, 2019-2025
19 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $52.71 · 2021: $14.89 · 2022: $51.02 · 2023: $379 · 2024: $244 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $426.15 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Amgen INC. | $107.30 | 2019-2020 | |
| Glaxosmithkline, LLC. | $85.61 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Pfizer INC. | $71.39 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.02 | 2019-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.30 | 2019-2024 | Trulance, Xifaxan |
| Abbvie INC. | $59.58 | 2023-2025 | Linzess, Vraylar |
| Sanofi Pasteur INC. | $58.03 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $57.22 | 2023-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Lilly USA, LLC | $57.07 | 2019-2023 | Jardiance |
| Ethicon US, LLC | $48.44 | 2019 | |
| Stryker Corporation | $44.97 | 2025 | Flowtriever |
| Dexcom, INC. | $22.16 | 2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $20.22 | 2022 | |
| Allergan, INC. | $19.52 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.26 | 2024 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $14.86 | 2023 | Gvoke Hypopen |
| Dynavax Technologies Corporation | $14.46 | 2023 | Heplisav-B |
| Amarin Pharma, INC. | $13.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.